Cargando…

Identification and in vitro validation of diagnostic and prognostic biomarkers for lung squamous cell carcinoma

BACKGROUND: The aim of the present study was to find diagnostic and prognostic biomarkers for lung squamous cell carcinoma (LUSC) and to validate key biomarkers in vitro. METHODS: RNA sequencing was used to identify differentially expressed mRNAs (DEmRNAs) and differentially expressed long non-codin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiaopeng, Yuan, Chong, He, Xu, Wang, Miao, Zhang, Haoran, Cheng, Jingge, Wang, Hongyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096289/ https://www.ncbi.nlm.nih.gov/pubmed/35572889 http://dx.doi.org/10.21037/jtd-22-343

Ejemplares similares

Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
por: Zhao, Xiaopeng, et al.
Publicado: (2022)

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
por: Sun, Yawei, et al.
Publicado: (2021)

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma
por: Yang, Zongcheng, et al.
Publicado: (2019)

Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma
por: Zhang, Shi-Long, et al.
Publicado: (2023)

Identification of prognostic immune subtypes of lung squamous cell carcinoma by unsupervised consistent clustering
por: Wang,, Yuhan, et al.
Publicado: (2023)

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019)

Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma
por: Liu, Huanqing, et al.
Publicado: (2022)

Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell Carcinoma
por: Liu, Hailin, et al.
Publicado: (2022)

Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis‐related genes
por: Diao, Xiayao, et al.
Publicado: (2021)

Identification and Validation of Prognostic Markers for Lung Squamous Cell Carcinoma Associated with Chronic Obstructive Pulmonary Disease
por: Li, Zheng, et al.
Publicado: (2022)

Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma
por: Wang, Jiawei, et al.
Publicado: (2023)

Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma
por: Li, Liang, et al.
Publicado: (2021)

Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma
por: Gao, Xujie, et al.
Publicado: (2016)

The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: An Immunohistochemical Study
por: Alabiad, Mohamed Ali, et al.
Publicado: (2021)

Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
por: Wang, Di, et al.
Publicado: (2022)

Identification and Validation of Novel Potential Pathogenesis and Biomarkers to Predict the Neurological Outcome after Cardiac Arrest
por: Zhang, Qiang, et al.
Publicado: (2022)

Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
por: Zhang, Mengxue, et al.
Publicado: (2021)

Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
por: Fan, Xiaoyan, et al.
Publicado: (2022)

Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Yan, Suzhen, et al.
Publicado: (2020)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Identification of KIF4A as a prognostic biomarker for esophageal squamous cell carcinoma
por: Wang, Lingwei, et al.
Publicado: (2021)

Identification of prognostically relevant gene signatures in lung squamous cell carcinoma by Lung Cancer Explorer
por: Wang, Yuqing, et al.
Publicado: (2021)

Identification of SPRR3 as a novel diagnostic/prognostic biomarker for oral squamous cell carcinoma via RNA sequencing and bioinformatic analyses
por: Yu, Lu, et al.
Publicado: (2020)

Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma
por: Zhang, Nana, et al.
Publicado: (2019)

Identification and Validation of HOTAIRM1 as a Novel Biomarker for Oral Squamous Cell Carcinoma
por: Yu, Yixiu, et al.
Publicado: (2022)

Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma
por: Cao, Bingji, et al.
Publicado: (2021)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma
por: Feng, Changjiang, et al.
Publicado: (2018)

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2019)

Immune Infiltration Represents Potential Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Li, Mengxiang, et al.
Publicado: (2022)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma
por: Xiong, Kai, et al.
Publicado: (2022)

Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
por: Wang, Jihan, et al.
Publicado: (2021)

Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma
por: Fang, Xisheng, et al.
Publicado: (2020)

Identification of NUTF2 as a Candidate Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Zhang, Rui, et al.
Publicado: (2021)

Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma
por: Gao, Xujie, et al.
Publicado: (2016)

Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma
por: Zhang, Yiping, et al.
Publicado: (2023)

Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma
por: Zhan, Ke, et al.
Publicado: (2021)

Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma
por: Fang, Jiayu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s942dru6dtdbjv1d9fiqapoq28